Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 92

Sort by

Sort Order Select

Journal Articles

Evaluating the Volumetric Liver Fat Fraction in Patients Referred for Investigation of Hyperferritinemia

Aoife Dervin, MBBS, BSc, MRCP, Perla Eleftheriou, FRCPath, MRCP, Deepak Suri, MBBS FRCP, Sara Trompeter, MBChB BSc MRCPCH FRCPath MSc, Maciej W Garbowski, MD PhD, Tim St. Pierre, John B. Porter, MA MDFRCP FRCPath, Emma Drasar, MBBS MRCP FRCPath PhD

Blood (2019) 134 (Supplement_1): 3539.

https://doi.org/10.1182/blood-2019-128122

Published: 2019

Journal Articles

Relation of Pancreatic Iron Overload Detected By MRI with Disorders of Glucose Metabolism and Results of Liver, Cardiac and Pitutiary MRI Among Transfusion Dependent Thalassemia (TDT) Patients in Turkey

Zeynep Karakas, Cihangir Sevimli, Nurdan Gul, Rana Comert, Memduh Dursun

Blood (2018) 132 (Supplement 1): 2350.

https://doi.org/10.1182/blood-2018-99-115356

Published: 2018

Journal Articles

Aceruloplasminemia and Paroxysmal Nocturnal Hemoglobinuria Uncover Differential Expressions of Ceruloplasmin and Ferroportin in Immune Cells

Marina Borges, BSc,MSc, Marina Dal'Bó Pelegrini Campioni, BSc, Dulcinéia Martins de Albuquerque, PhD, Carolina Lanaro, PhD, Fernando F. Costa, MD, PhD, Kleber Yotsumoto Fertrin, MD PhD

Blood (2018) 132 (Supplement 1): 4895.

https://doi.org/10.1182/blood-2018-99-113485

Published: 2018

Journal Articles

Serum Ferritin Underestimates Liver Iron Concentration in Patients with Homozygous Alpha-0 Thalassemia

Ali Amid, MD, Shiyi Chen, Uma Athale, Karen Charpentier, Manuela Merelles-Pulcini, Isaac Odame, Melanie Ann Kirby-Allen

Blood (2017) 130 (Supplement 1): 3504.

https://doi.org/10.1182/blood.V130.Suppl_1.3504.3504

Published: 2017

Journal Articles

RNAi and CRISPR/Cas9 Based In Vivo Models for Drug Discovery

Prem Premsrirut, MD PhD, Chia-Lin Wang, PhD, Yu-ting Yang, PhD, Christof Fellmann, PhD, Lukas Dow, PhD, Johannes Zuber, PhD, Scott Lowe, PhD, Marina Pesic, PhD, Katharina Wolter, PhD, Lars Zender, PhD

Blood (2017) 130 (Supplement 1): 5568.

https://doi.org/10.1182/blood.V130.Suppl_1.5568.5568

Published: 2017

Journal Articles

Optimizing the Management of Iron Overload in Patients with Hemoglobin Disorders in Centers with Limited Access to Magnetic Resonance Imaging

Alvaro Henrique Junqueira Tavares, BS, Otavio Rizzi Coelho-Filho, MD PhD, Sara Teresinha Olalla Saad, MD PhD, Fernando Ferreira Costa, MD PhD, Kleber Yotsumoto Fertrin, MD PhD

Blood (2017) 130 (Supplement 1): 5575.

https://doi.org/10.1182/blood.V130.Suppl_1.5575.5575

Published: 2017

Journal Articles

Absence of T1 Hyperintensity in the Brain of Thalassemia Patients after Multiple Administrations of Gadobutrol

Antonella Meloni, PhD, Domenico Montanaro, Daniele De Marchi, Maria Chiara Resta, Petra Keilberg, Laura Pistoia, MD, Anna Spasiano, Tommaso Casini, Caterina Cinzia De Bari, Sara De Cori, Vincenzo Positano, Paolo Di Bartolomeo, MD, Alessia Pepe, MD

Blood (2017) 130 (Supplement 1): 4767.

https://doi.org/10.1182/blood.V130.Suppl_1.4767.4767

Published: 2017

Journal Articles

Longitudinal Serum Ferritin Cut-Off Level for Cardiac Iron Overload Prediction in Transfusion-Dependent Thalassemia in a Resource Limited Country

Supachai Ekwattanakit, PhD MD, Pairash Saiviroonporn, PhD, Kleebsabai Sanpakit, MD, Noppadol Siritanaratkul, MD, Jassada Buaboonnam, MD, Archrob Khuhapinant, PhD MD, Boonying Rerkudom, Stephan Erberich, PhD, John C Wood, MD PhD, Rungroj Krittayaphong, MD, Vip Viprakasit, MD DPhil

Blood (2016) 128 (22): 1282.

https://doi.org/10.1182/blood.V128.22.1282.1282

Published: 2016

Journal Articles

A MRI Prospective Survey on Heart and Liver Iron and Cardiac Function in Thalassemia Major Patients Treated with Deferasirox Versus Deferiprone and Desferrioxamine in Monotherapy

Alessia Pepe, Laura Pistoia, Liana Cuccia, Monica Fortini, Vincenzo Caruso, MD, Rosamaria Rosso, Saveria Campisi, Angelo Peluso, Francesco Sorrentino, Aurelio Maggio, MD, Vincenzo Positano, Giuseppe Peritore, Antonella Meloni

Blood (2016) 128 (22): 3631.

https://doi.org/10.1182/blood.V128.22.3631.3631

Published: 2016

Journal Articles

Progression of Liver Fibrosis Can be Controlled Under Adequate Chelation in Transfusion-Dependent Thalassemia (TDT).

Diletta Maira, MD, Elena Cassinerio, MD, Alessia Marcon, MD, Marta Mancarella, MD, Mirella Fraquelli, MD, Maria Domenica Cappellini, MD

Blood (2016) 128 (22): 3632.

https://doi.org/10.1182/blood.V128.22.3632.3632

Published: 2016

Journal Articles

Association Between Cardiac Iron Clereance and Hepatic Siderosis

Alessia Pepe, Laura Pistoia, Domenico D'Ascola, MD, Maria Rita Gamberini, Francesco Gagliardotto, Aldo Filosa, MD, Carla Cirotto, Tommaso Casini, Aurelio Maggio, MD, Ada Riva, Vincenzo Positano, Antonella Meloni

Blood (2016) 128 (22): 4833.

https://doi.org/10.1182/blood.V128.22.4833.4833

Published: 2016

Journal Articles

A randomized trial of amlodipine in addition to standard chelation therapy in patients with thalassemia major

Juliano L. Fernandes, Sandra R. Loggetto, Monica P. A. Veríssimo, Kleber Y. Fertrin, Giorgio R. Baldanzi, Luciana A. B. Fioravante, Doralice M. Tan, Tatiana Higa, Denise A. Mashima, Antonio Piga, Otavio R. Coelho, Fernando F. Costa, Sara T. Saad

Blood (2016) 128 (12): 1555–1561.

https://doi.org/10.1182/blood-2016-06-721183

Published: 2016

Includes: Supplemental data

Journal Articles

Association of Liver Iron Concentration Levels with Myocardial T2* Responses in Transfusion-Dependent Thalassemia Major Patients Treated with Deferasirox and Deferoxamine- Extension of Cordelia Study

Dudley J Pennell, John B Porter, Antonio Piga, Jackie Han, Alexander Vorog, Yesim Aydinok

Blood (2015) 126 (23): 2155.

https://doi.org/10.1182/blood.V126.23.2155.2155

Published: 2015

Journal Articles

Significant Improvement of Survival By T2* Cardiovascular Magnetic Resonance in Thalassemia Major

Alessia Pepe, Antonella Meloni, Giovanni Carlo Del Vecchio, Maria Antonietta Romeo, Maria Rita Gamberini, Federico Bonetti, Maria Giovanna Neri, Elisabetta Chiodi, Vincenzo Positano, Aurelio Maggio, MD, Caterina Borgna-Pignatti, MD

Blood (2015) 126 (23): 4567.

https://doi.org/10.1182/blood.V126.23.4567.4567

Published: 2015

Journal Articles

Bone Marrow Iron Assessment By MRI-R2* and Its Relation to Deferasirox Treatment in Patients with Iron Overload

Regine Grosse, MD, Suzan Acar, Bjoern Schoennagel, MD, Roland Fischer, PhD, Jin Yamamura, MD, Gritta Janka, MD PhD, Peter Nielsen, MD

Blood (2015) 126 (23): 3358.

https://doi.org/10.1182/blood.V126.23.3358.3358

Published: 2015

Journal Articles

Residual Erythropoiesis Protects Against Cardiac Iron Loading in Transfusion Dependent Thalassaemia (TDT) By Lowering Labile Plasma Iron (LPI) through Transient Apotransferrin Generation

Maciej W. Garbowski, MD, Patricia Evans, PhD, John B Porter

Blood (2015) 126 (23): 539.

https://doi.org/10.1182/blood.V126.23.539.539

Published: 2015

Journal Articles

Prevalence of Cardiac and Hepatic Siderosis in Australian Patients with Transfusion-Dependent Anemias or Non-Transfusion-Dependent Thalassemia, As Assessed By MRI (the TIMES study)

Phoebe Joy Ho, Devendra Hiwase, MBBS, FRACP, FRCPA, MD PhD, Raj Ramakrishna, Nicholas Viiala, David M Ross, MBBS, PhD FRACP, FRCPA, Evren Zor, Othon L Gervasio, Donald Bowden

Blood (2015) 126 (23): 540.

https://doi.org/10.1182/blood.V126.23.540.540

Published: 2015

Journal Articles

Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload

Yesim Aydinok, Antonis Kattamis, M. Domenica Cappellini, Amal El-Beshlawy, Raffaella Origa, Mohsen Elalfy, Yurdanur Kilinç, Silverio Perrotta, Zeynep Karakas, Vip Viprakasit, Dany Habr, Niculae Constantinovici, Junwu Shen, John B. Porter

Blood (2015) 125 (25): 3868–3877.

https://doi.org/10.1182/blood-2014-07-586677

Published: 2015

Includes: Supplemental data

Journal Articles

Hereditary Hemochromatosis in an Adult Due to H63D Mutation: The Value of Estimating Iron Deposition By MRI T2* and Dissociation Between Serum Ferritin Concentration and Hepatic Iron Overload

Mohamed A. Yassin, MBBS, MSc, CABM, FACP, Ashraf T Soliman, MDFRCP PhD, Vincenzo Desanctis, MD, Sandara Abusamaan, MD, Ahmed Elsotouhy, MD, Nader Aldewik, MSc PhD

Blood (2014) 124 (21): 4891.

https://doi.org/10.1182/blood.V124.21.4891.4891

Published: 2014

Journal Articles

Lack of Cardiac Iron in SCD Patients Despite Severe Iron Overload

Rasha I Ahmad, MD, Sara Keyrouz, Research coordinator, Mariam Arabi, MD, Fadi Bitar, MD, Wael al Jaroudi, MD, Miguel Abboud, MDHematologist

Blood (2014) 124 (21): 4943.

https://doi.org/10.1182/blood.V124.21.4943.4943

Published: 2014

NARROW

Evaluating the Volumetric Liver Fat Fraction in Patients Referred for Investigation of Hyperferritinemia

Relation of Pancreatic Iron Overload Detected By MRI with Disorders of Glucose Metabolism and Results of Liver, Cardiac and Pitutiary MRI Among Transfusion Dependent Thalassemia (TDT) Patients in Turkey

Aceruloplasminemia and Paroxysmal Nocturnal Hemoglobinuria Uncover Differential Expressions of Ceruloplasmin and Ferroportin in Immune Cells

Serum Ferritin Underestimates Liver Iron Concentration in Patients with Homozygous Alpha-0 Thalassemia

RNAi and CRISPR/Cas9 Based In Vivo Models for Drug Discovery

Optimizing the Management of Iron Overload in Patients with Hemoglobin Disorders in Centers with Limited Access to Magnetic Resonance Imaging

Absence of T1 Hyperintensity in the Brain of Thalassemia Patients after Multiple Administrations of Gadobutrol

Longitudinal Serum Ferritin Cut-Off Level for Cardiac Iron Overload Prediction in Transfusion-Dependent Thalassemia in a Resource Limited Country

A MRI Prospective Survey on Heart and Liver Iron and Cardiac Function in Thalassemia Major Patients Treated with Deferasirox Versus Deferiprone and Desferrioxamine in Monotherapy

Progression of Liver Fibrosis Can be Controlled Under Adequate Chelation in Transfusion-Dependent Thalassemia (TDT).

Association Between Cardiac Iron Clereance and Hepatic Siderosis

A randomized trial of amlodipine in addition to standard chelation therapy in patients with thalassemia major

Association of Liver Iron Concentration Levels with Myocardial T2* Responses in Transfusion-Dependent Thalassemia Major Patients Treated with Deferasirox and Deferoxamine- Extension of Cordelia Study

Significant Improvement of Survival By T2* Cardiovascular Magnetic Resonance in Thalassemia Major

Bone Marrow Iron Assessment By MRI-R2* and Its Relation to Deferasirox Treatment in Patients with Iron Overload

Residual Erythropoiesis Protects Against Cardiac Iron Loading in Transfusion Dependent Thalassaemia (TDT) By Lowering Labile Plasma Iron (LPI) through Transient Apotransferrin Generation

Prevalence of Cardiac and Hepatic Siderosis in Australian Patients with Transfusion-Dependent Anemias or Non-Transfusion-Dependent Thalassemia, As Assessed By MRI (the TIMES study)

Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload

Hereditary Hemochromatosis in an Adult Due to H63D Mutation: The Value of Estimating Iron Deposition By MRI T2* and Dissociation Between Serum Ferritin Concentration and Hepatic Iron Overload

Lack of Cardiac Iron in SCD Patients Despite Severe Iron Overload

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only